222 related articles for article (PubMed ID: 36768939)
41. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
42. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
Chung H; Lee S; Kim GA; Kim WH
PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
[TBL] [Abstract][Full Text] [Related]
43. Molecular carcinogenesis of canine mammary tumors: news from an old disease.
Klopfleisch R; von Euler H; Sarli G; Pinho SS; Gärtner F; Gruber AD
Vet Pathol; 2011 Jan; 48(1):98-116. PubMed ID: 21149845
[TBL] [Abstract][Full Text] [Related]
44. Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry.
Fhaikrue I; Srisawat W; Nambooppha B; Pringproa K; Thongtharb A; Prachasilchai W; Sthitmatee N
Vet Comp Oncol; 2020 Dec; 18(4):787-795. PubMed ID: 32421920
[TBL] [Abstract][Full Text] [Related]
45. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA expression in canine mammary cancer.
Boggs RM; Wright ZM; Stickney MJ; Porter WW; Murphy KE
Mamm Genome; 2008 Aug; 19(7-8):561-9. PubMed ID: 18665421
[TBL] [Abstract][Full Text] [Related]
47. Expression and significance of CHIP in canine mammary gland tumors.
Wang H; Yang X; Jin Y; Pei S; Zhang D; Ma W; Huang J; Qiu H; Zhang X; Jiang Q; Sun W; Zhang H; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1465-71. PubMed ID: 26156079
[TBL] [Abstract][Full Text] [Related]
48. Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.
Tanaka T; Shimada T; Akiyoshi H; Shimizu J; Zheng C; Yijyun L; Mie K; Hayashi A; Kuwamura M; Hoshi F; Ohashi F
J Vet Med Sci; 2013 Oct; 75(10):1393-8. PubMed ID: 23728200
[TBL] [Abstract][Full Text] [Related]
49. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
50. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
51. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
53. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
54. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
55. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
56. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
57. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
58. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
59. Carnitine palmitoyltransferase 1 A expression profile in canine mammary tumors.
Cacciola NA; Sgadari M; Petillo O; Margarucci S; Martano M; Cocchia N; Maiolino P; Restucci B
Vet J; 2020 Mar; 257():105453. PubMed ID: 32546357
[TBL] [Abstract][Full Text] [Related]
60. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
